Clinical Trial Update: Eptinezumab as Preventive Treatment of Migraine in Adults With Migraine [Phase 3]

View source ↗

Summary

Phase 3 study evaluating eptinezumab as a preventive treatment for adults with migraine has completed. The trial was sponsored by H. Lundbeck A/S.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• VYEPTI (eptinezumab)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Migraine | Phase 3 | Status: COMPLETED